INTRODUCTION
Tumor necrosis factor (TNF) and lymphotoxin a (LTa) are mediators of inflammation and immune response (1, 2) and are prototypic members of a growing family of TNF-like ligands (3) (4) (5) (6) (7) . Both ligands form homotrimers and bind to two different receptors, tumor necrosis factor receptor 1 (TNFR-1) and TNFR-2 (6, (8) (9) (10) . The genetic inactivation of the TNFR-1 (11, 12) and the TNF-LTa system, since it has neither the two ligands signaling through the TNFR-1 and -2 nor that signaling through the LTf3-R (18 
MATERIALS AND METHODS
Mice TNF-LTa knock-out mice were generated as described on a mixed genetic 129/Ev/Sv x C57BL/6 background (18) . Seven-to ten-weekold wild-type and knock-out mice bred in our animal facility and maintained under specific pathogen-free conditions were utilized.
Reagents
Antibodies used in flow cytometry and FACS analysis were rat anti-mouse monoclonal antibodies (mAb) F4 (19) .
Stimulation of Macrophages and Splenocytes
Bone marrow-derived macrophages were isolated from femurs and cultivated (106/ml) for 7 days in Dulbecco's minimal essential medium (DMEM) supplemented with 20% horse serum and 30% L929 cell-conditioned medium (as source of M-CSF). After 7 days of culture, the cell preparation contains 99% macrophages (20) . The bone marrow-derived macrophages were stimulated with LPS (10 ng/ml) for 3 hr and the supernatant was assessed for TNF activity as described (19) . Freshly isolated splenocytes were stimulated with concanavalin-A (5 ,ug/ml) for 20 hr. Transcripts for TNF and LTa were determined from total RNA by RT-PCR according to standard protocols (18 (Fig. iB) .
In addition, after concanavalin-A stimulation splenocytes from mutant mice reconstituted with wild-type bone marrow expressed similar amounts of TNF and LTa mRNA compared with wild-type splenocytes (Fig. 1 C) By contrast, correction of the TNF-LTa deficiency by wild-type marrow reconstitution restored the regular splenic architecture with the distinct separation of T and B cell areas (Fig. 3A) , the correct expression of MAdCAM-1 in the marginal sinus and the formation of germinal centers upon antigenic stimulation (not shown). Fig. 4 A-D) . The block of Ig class switching could be transferred to adult wild-type mice by transplantation of TNF-LTadeficient bone marrow (Fig. 4 A-D (17, 26) , while the TNFR-1 and -2 had normal splenic structure (1 1-13) . Therefore, the correct formation of the spleen appears to be controlled by the LTa-f3 heteromer signaling through the LT /3-R in postnatal development. In addition, the altered splenic microarchitecture seems to be a reversible process, which suggests that LTa expression contributes to splenic differentiation. The data demonstrate that the developmental pathways for lymph nodes and spleen are different.
The increase of peripheral lymphocyte counts seen in TNF-LTa-deficient mice was considered to be due to the lack of lymph node structures. However, there seems to be no causal relationship between the two events, our experimental setting having allowed us to separate them. The lymphocyte count was normalized in TNF-LTa-deficient mice reconstituted with wildtype bone marrow cells, although no lymph node structures were induced. Conversely, the lymphocyte counts were significantly above normal levels in wild-type mice reconstituted with mutant bone marrow cells (18.6 ± 1.6 X 103/pl versus 8.3 ± 0.8 X 103/1I on Day 42 post-transplantation in three independent experiments; n = 9-10 mice), although the lymph nodes were present and repopulated (not shown). The lymphocytosis in wild-type mice reconstituted with TNF-LTa-deficient bone marrow was stable be- 10-1 1) and was still seen beyond 5 months (21.4 ± 3.5 X 103/pI versus 10.0 ± 1.5 X 103/pl, n = 3-4). It never reached the level of lymphocytosis normally seen in naive TNF-LTa-deficient mice (42.6 ± 2.3 X 103/,ul, n = 28), a result which would be explained by the minimal residual TNF levels ( Fig. IA) and residual mRNA expression by splenic T cells in these mice (Fig. IC) .
Our results are in agreement with the fact that aly mice, a mutant mouse strain, which are also devoid of lymph nodes, have normal peripheral lymphocyte counts (27) . The findings suggest that the peripheral lymphocyte count is not controlled by lymph nodes and, rather, that the TNF-LTa-deficient lymphocytes have a homing defect.
Since no defect in the Ig class switch has been observed in TNFR-1-and -2-deficient mice (1 1-13), we propose that it is the signal from the LTa-f3 heteromer through the LT,B-R that is necessary for isotype switching. In addition, the data presented here demonstrate that the defective Ig class switch can be corrected by wild-type bone marrow transplantation (e.g., by introduction of TNF-LTa-producing cells during adult life of the recipient). The similarities of the immune defect between TNF-LTa--deficient and CD40 and CD40 ligand (L) knock-out mice are striking. Indeed, a similar defect of Ig class switch in response to the thymus-dependent antigen, trinitrophenyl-conjugated keyhole limpet hemocyanin (TNP-KLH), was reported for CD40-and CD40L-deficient mice (28, 29 (30) . It has also been shown that TNF expressed on the membrane of CD4+ T cells, together with the TNFR1, participate in T-B cell interactions resulting in enhanced immunoglobulin production (31, 32) .
In conclusion, transplantation of normal bone marrow into TNF-LTa-mutant mice allowed functional and to some extent morphological correction of the immune defect seen in the TNF-LTa-deficient mice. Conversely, the mutant phenotype could be transferred by bone marrow cells transplanted into wild-type recipient mice.
These finding not only provide interesting information on the origin of the cells producing TNF and LTa, but may have important therapeutic implications for the restoration of genetically defined immunodeficiencies. Several forms of immunodeficiencies in humans have been described, and the corresponding genetic defects identified. Mutations in the CD40 ligand, a member of the TNF gene family, have been found in X-linked hyper-IgM syndrome (29) . While no inactivation of the TNF or LTa genes has been reported so far, there is a substantial polymorphism in human TNF and LTa genes, which is associated with autoimmune disorders. It is very likely that mutations of the TNF and/or LT locus will be identified that are responsible for as yet undiscovered immunodeficiencies in humans.
